Gene · 9232
Papers3,322
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,322
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ERBB2 as a prognostic biomarker correlates with immune infiltrates in papillary thyroid cancer. | Front Genet | 2022 | 36437939 | PubTator, text mining | PubMed |
| Aptamer-Based Probes for Cancer Diagnostics and Treatment. | Life (Basel) | 2022 | 36431072 | PubTator, text mining | PubMed |
| Statins as Repurposed Drugs in Gynecological Cancer: A Review. | Int J Mol Sci | 2022 | 36430409 | PubTator, text mining | PubMed |
| Signatures of Breast Cancer Progression in the Blood: What Could Be Learned from Circulating Tumor Cell Transcriptomes. | Cancers (Basel) | 2022 | 36428760 | PubTator, text mining | PubMed |
| BUBR1 as a Prognostic Biomarker in Canine Oral Squamous Cell Carcinoma. | Animals (Basel) | 2022 | 36428310 | PubTator, text mining | PubMed |
| Single-cell transcriptomic mapping of intestinal epithelium that undergoes 3D morphogenesis and mechanodynamic stimulation in a gut-on-a-chip. | iScience | 2022 | 36425760 | PubTator, text mining | PubMed |
| RNA-triggered protein cleavage and cell growth arrest by the type III-E CRISPR nuclease-protease. | Science | 2022 | 36423304 | PubTator, text mining | PubMed |
| Recent Updates on Source, Biosynthesis, and Therapeutic Potential of Natural Flavonoid Luteolin: A Review. | Metabolites | 2022 | 36422285 | PubTator, text mining | PubMed |
| A novel senescence-related lncRNA signature that predicts prognosis and the tumor microenvironment in patients with lung adenocarcinoma. | Front Genet | 2022 | 36406130 | PubTator, text mining | PubMed |
| Accurate Identification of DNA Replication Origin by Fusing Epigenomics and Chromatin Interaction Information. | Research (Wash D C) | 2022 | 36405252 | PubTator, text mining | PubMed |
| Clinical Applications of Aneuploidies in Evolution of NSCLC Patients: Current Status and Application Prospect. | Onco Targets Ther | 2022 | 36388157 | PubTator, text mining | PubMed |
| Identification and validation of ubiquitin-proteasome system related genes as a prognostic signature for papillary renal cell carcinoma. | Aging (Albany NY) | 2022 | 36385010 | PubTator, text mining | PubMed |
| Sp4 Regulates PTTG1IP Gene Transcription and Expression. | DNA Cell Biol | 2022 | 36383136 | PubTator, text mining | PubMed |
| Insight into the physiological and pathological roles of USP44, a potential tumor target (Review). | Oncol Lett | 2022 | 36380875 | PubTator, text mining | PubMed |
| SGOL2 is a novel prognostic marker and fosters disease progression via a MAD2-mediated pathway in hepatocellular carcinoma. | Biomark Res | 2022 | 36380369 | PubTator, text mining | PubMed |
| Genetics of Oocyte Maturation Defects and Early Embryo Development Arrest. | Genes (Basel) | 2022 | 36360157 | PubTator, text mining | PubMed |
| Epigenetic-Mediated Regulation of Gene Expression for Biological Control and Cancer: Cell and Tissue Structure, Function, and Phenotype. | Results Probl Cell Differ | 2022 | 36348114 | PubTator, text mining | PubMed |
| Evaluating anticancer properties of Withaferin A-a potent phytochemical. | Front Pharmacol | 2022 | 36339589 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| Perfluoroalkyl substances (PFASs) decrease the expression of recombination-activating genes (RAG1 and RAG2) in human B lymphoma Namalwa cells. | Arch Toxicol | 2022 | 36326898 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9232/papers?page=21